Literature DB >> 24965077

Outcomes in the management of adult soft tissue sarcomas.

Jeffrey S Kneisl1, Michelle M Coleman, Chandrajit P Raut.   

Abstract

Adult soft tissue sarcomas (STSs) are heterogeneous neoplasms that account for 11,410 new diagnoses and 4,390 deaths per year. This article summarizes recent NCCN guidelines for diagnosis and management of STSs of the extremities and retroperitoneum, as well as gastrointestinal stromal tumors (GIST). AJCC staging and recently reported NCDB data regarding outcomes are reviewed. Currently accepted STS prognostic variables are presented, as are future directions regarding the utility of molecular prognosticators and nomograms.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastrointestinal stromal tumor; management; outcomes; retroperitoneal sarcoma; soft tissue sarcoma

Mesh：

Year:  2014        PMID： 24965077     DOI： 10.1002/jso.23685

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  14 in total

1.  Epithelioid Sarcoma in the Cervical Spine: A Case Report.

Authors:  Chungnam Lee; Woo Jin Choe; Nara Kim
Journal:  Korean J Spine       Date:  2015-09-30

2.  Clinical characteristics of patients with large and deep soft tissue sarcomas.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Astumasa Uchida; Akihiro Sudo
Journal:  Oncol Lett       Date:  2015-05-28       Impact factor: 2.967

3.  Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.

Authors:  Valentina Di Gialleonardo; Hannah N Aldeborgh; Vesselin Miloushev; Kelly M Folkers; Kristin Granlund; William D Tap; Jason S Lewis; Wolfgang A Weber; Kayvan R Keshari
Journal:  Cancer Res       Date:  2017-04-06       Impact factor: 12.701

4.  Use of negative pressure wound therapy as an adjunct to the treatment of extremity soft-tissue sarcoma with ulceration or impending ulceration.

Authors:  Y U Chen; Song-Feng Xu; Ming Xu; Xiu-Chun Yu
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

5.  PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC.

Authors:  Patrick B Schwartz; George Poultsides; Kevin Roggin; John H Howard; Ryan C Fields; Callisia N Clarke; Konstantinos Votanopoulos; Kenneth Cardona; Emily R Winslow
Journal:  J Surg Res       Date:  2020-03-12       Impact factor: 2.192

6.  High expression of SDF-1 and VEGF is associated with poor prognosis in patients with synovial sarcomas.

Authors:  Qi Feng; Peng Guo; Jin Wang; Xiaoyu Zhang; Hui-Chai Yang; Jian-Gang Feng
Journal:  Exp Ther Med       Date:  2018-01-02       Impact factor: 2.447

7.  Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.

Authors:  Tyler Abarca; Yubo Gao; Varun Monga; Munir R Tanas; Mohammed M Milhem; Benjamin J Miller
Journal:  J Surg Oncol       Date:  2018-04-06       Impact factor: 3.454

8.  Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.

Authors:  Eihab Abdelfatah; Angela A Guzzetta; Neeraja Nagarajan; Christopher L Wolfgang; Timothy M Pawlik; Michael A Choti; Richard Schulick; Elizabeth A Montgomery; Christian Meyer; Katherine Thornton; Joseph Herman; Stephanie Terezakis; Deborah Frassica; Nita Ahuja
Journal:  J Surg Oncol       Date:  2016-04-13       Impact factor: 3.454

9.  Leiomyosarcoma of the renal vein: analysis of outcome and prognostic factors in the world case series of 67 patients.

Authors:  Marko Novak; Andraz Perhavec; Katherine E Maturen; Snezana Pavlovic Djokic; Simona Jereb; Darja Erzen
Journal:  Radiol Oncol       Date:  2016-12-23       Impact factor: 2.991

10.  Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.

Authors:  Florian Posch; Richard Partl; Carmen Döller; Jakob M Riedl; Maria Smolle; Lukas Leitner; Marko Bergovec; Bernadette Liegl-Atzwanger; Michael Stotz; Angelika Bezan; Armin Gerger; Martin Pichler; Karin S Kapp; Herbert Stöger; Andreas Leithner; Joanna Szkandera
Journal:  Ann Surg Oncol       Date:  2017-09-11       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.